1 Min Read
Nov 15 (Reuters) - Akers Biosciences Inc-
* Akers Biosciences announces Q3 2017 earnings
* Q3 revenue rose 10 percent to $675,800
* Akers Biosciences Inc - Q3 gross margin reduced to 52% Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.